Moreover, elevated CCL3 and CCL4 levels have been shown to be normalized by the Btk inhibitor in patients with CLL [14, 15], indicating that the BCR signaling pathway is responsible for chemokine production. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.